SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001169245-21-000034
Filing Date
2021-05-13
Accepted
2021-05-13 16:06:31
Documents
34
Period of Report
2021-05-13
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kxearningsrelease2021q1.htm 8-K 28195
2 EX-99.1 ex991-earningsrelease2021q1.htm EX-99.1 60064
3 EX-99.2 phasebiocorporateovervie.htm EX-99.2 40321
4 phasebio2020logo1.jpg GRAPHIC 27705
5 GRAPHIC phasebiocorporateovervie001.jpg GRAPHIC 67540
6 GRAPHIC phasebiocorporateovervie002.jpg GRAPHIC 190271
7 GRAPHIC phasebiocorporateovervie003.jpg GRAPHIC 148814
8 GRAPHIC phasebiocorporateovervie004.jpg GRAPHIC 112947
9 GRAPHIC phasebiocorporateovervie005.jpg GRAPHIC 35331
10 GRAPHIC phasebiocorporateovervie006.jpg GRAPHIC 128775
11 GRAPHIC phasebiocorporateovervie007.jpg GRAPHIC 109546
12 GRAPHIC phasebiocorporateovervie008.jpg GRAPHIC 61524
13 GRAPHIC phasebiocorporateovervie009.jpg GRAPHIC 45766
14 GRAPHIC phasebiocorporateovervie010.jpg GRAPHIC 142085
15 GRAPHIC phasebiocorporateovervie011.jpg GRAPHIC 97031
16 GRAPHIC phasebiocorporateovervie012.jpg GRAPHIC 123194
17 GRAPHIC phasebiocorporateovervie013.jpg GRAPHIC 111445
18 GRAPHIC phasebiocorporateovervie014.jpg GRAPHIC 128104
19 GRAPHIC phasebiocorporateovervie015.jpg GRAPHIC 125028
20 GRAPHIC phasebiocorporateovervie016.jpg GRAPHIC 131645
21 GRAPHIC phasebiocorporateovervie017.jpg GRAPHIC 120770
22 GRAPHIC phasebiocorporateovervie018.jpg GRAPHIC 131886
23 GRAPHIC phasebiocorporateovervie019.jpg GRAPHIC 150050
24 GRAPHIC phasebiocorporateovervie020.jpg GRAPHIC 136880
25 GRAPHIC phasebiocorporateovervie021.jpg GRAPHIC 102810
26 GRAPHIC phasebiocorporateovervie022.jpg GRAPHIC 58210
27 GRAPHIC phasebiocorporateovervie023.jpg GRAPHIC 96192
28 GRAPHIC phasebiocorporateovervie024.jpg GRAPHIC 112819
29 GRAPHIC phasebiocorporateovervie025.jpg GRAPHIC 112884
30 GRAPHIC phasebiocorporateovervie026.jpg GRAPHIC 120538
31 GRAPHIC phasebiocorporateovervie027.jpg GRAPHIC 50463
32 GRAPHIC phasebiocorporateovervie028.jpg GRAPHIC 146588
33 GRAPHIC phasebiocorporateovervie029.jpg GRAPHIC 123316
34 GRAPHIC phasebiocorporateovervie030.jpg GRAPHIC 59935
  Complete submission text file 0001169245-21-000034.txt   4693137
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 21919603
SIC: 2834 Pharmaceutical Preparations